Cohen & Company Inc Dossier - Source-backed chat

Cohen & Company Inc

COHNNYSE

SectorFinancials

IndustryInvestment Banking & Brokerage

Beta (adjusted)1.08

Intrinsic Value

No headline value published yetWe haven't published a headline intrinsic value for this company yet. Our data-reliability standards weren't met. Method estimates are shown for reference.

Market Price $9.58Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $30.9M

Enterprise Value $19.6M

Shares Outstanding 3.2M diluted

Moat Rating Wide

Next Earnings Date4 Nov 2026

Last ex-dividend19 Aug 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Cohen & Co Inc. (COHN) represents a highly compelling, deeply undervalued micro-cap financial services play. The company has successfully pivoted toward a high-margin boutique investment banking model (via Cohen & Company Capital Markets - CCM), which drove a massive 246% YoY revenue surge to $275.6 million in 2025. Despite generating substantial earnings per share ($4.54 TTM diluted EPS) and maintaining a robust balance sheet with a $3.9 billion gestation repo book, the stock trades at a massive discount to its book value (P/B of ~0.5x) and a trailing P/E of under 3x. This extreme valuation disconnect is primarily driven by market over-caution regarding the cyclicality of its SPAC and principal investing segments. However, with strong recurring fee-like revenues from its sales & trading and asset management divisions, alongside aggressive expansion into frontier technologies, the risk-reward profile is heavily skewed to the upside.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets1 analysts · as of 18 Aug 2026

Low · most bearish analyst$20.00

Mean target$20.00

High · most bullish analyst$20.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$8.5020%

A severe downturn in capital markets freezes SPAC transactions and De-SPAC advisory, which currently account for the majority of CCM's revenue. Principal investing segment suffers outsized mark-to-market losses on high-risk equity holdings. High fixed compensation costs (currently ~71% of revenue) compress operating margins, forcing a reduction in the dividend.

Base CaseCentral scenario

$18.0050%

Investment banking revenues remain stable, supported by repeat sponsor relationships and steady middle-market advisory. The company maintains its quarterly dividend of $0.25 per share (yielding over 8.5% at current prices). The stock experiences moderate multiple expansion as consistent profitability assuages cyclicality concerns, trading up to a conservative 0.8x book value.

Bull CaseUpside scenario

$25.0030%

The investment banking pipeline accelerates further, driven by a resurgence in SPAC IPOs/M&As and successful expansion into frontier technology sectors (digital assets, space tech). Fixed income trading revenues hit the high end of management's 2027 target ($65 million), and the gestation repo book continues to scale. The market re-rates COHN closer to its boutique advisory peers, closing the book value discount.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Extreme valuation discount trading at ~0.5x book value and a trailing P/E of ~2.5x.
Strong revenue momentum with 2025 revenue up 246% YoY to $275.6 million, driven by the high-margin CCM division.
High dividend yield with a recurring quarterly dividend of $0.25 per share, supplemented by historical special dividends.
Robust liquidity and asset quality, with over 50% of assets tied to short-term, high-quality gestation repo arrangements.

Key Investment Risks

High revenue concentration and cyclicality tied to SPAC IPO and M&A transaction volumes.
Elevated operating leverage with compensation and benefits expenses consuming ~71% of revenue in Q1 2026.
Potential mark-to-market volatility in the Principal Investing segment from high-risk equity holdings.

Thesis Invalidation Triggers

A prolonged freeze in the SPAC and IPO markets lasting more than three consecutive quarters.
A material reduction or suspension of the recurring quarterly dividend.
Operating margins turning negative due to failure to scale down compensation expenses during a revenue contraction.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.